Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206. Harriet M. Kluger, Susan Halabi, Nicole C Solomon, Lucia Jilaveanu, Christopher Zito, Joshua Sznol, Andrew B. Nixon, Brian I. Rini, Eric Jay Small, Daniel J. George;
| Autor: | Zito, Christopher R, Kluger, Harriet M., Jilaveauanu, Lucia B., Kluger, Yuval, Halabi, Susan, Solomon, Nicole C, Sznol, Joshua, Nixon, Andrew B., Rini, Brian I., Small, Eric Jay, George, Daniel J. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| DOI: | 10.13140/2.1.1151.9046 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|